Cancer will kill 1.3 million Europeans this year
This article was originally published in Scrip
New figures published in the cancer journal Annals of Oncology estimate that nearly 1.3 million Europeans will die from cancer in 2012. While the number of people succumbing to cancer has risen, the good news is that the rate (age-standardised per 100,000 population) of people who die from the disease continues to decline.
You may also be interested in...
Cambridge, UK-based Healx has concluded a $56m series B round, led by Atomico, to put up to 50 potential rare disease treatments into the clinic within two years using its AI/ML platform.
Tapping into the ability of arenaviruses to deliver prolonged local immune activation, rapid regression of localized and metastatic cancers, and long-term disease control, Essen, Germany-based start-up Abalos Therapeutics has raised €12m to advance its lead candidates towards clinical testing.
Celgene agrees to pay $75m upfront for options to three Immatics TCR-T targets for solid tumors. Deal could be worth up to $1.59bn to the German biotech, which also retains option to co-develop and co-fund certain licensed products.